Argenx
ARGX
#567
Rank
S$48.23 B
Marketcap
$790.87
Share price
-0.73%
Change (1 day)
48.82%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Argenx (ARGX) - Total assets

Total assets on the balance sheet as of December 2024 : S$8.32 Billion

According to Argenx 's latest financial reports the company's total assets are S$8.32 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Argenx - Total assets on balance sheet (from 2021 to 2020)

Total assets by year

Year Total assets Change
2024-12-31S$8.43 B40.53%
2023-12-31S$5.99 B42.78%
2022-12-31S$4.20 B9.04%
2021-12-31S$3.85 B3.89%
2020-12-31S$3.70 B52.52%
2019-12-31S$2.43 B135.16%
2018-12-31S$1.03 B44.82%
2017-12-31S$0.71 B321.68%
2016-12-31S$0.16 B117.89%
2015-12-31S$77.71 M-32.03%
2014-12-31S$0.11 B89.19%
2013-12-31S$60.43 M62.93%
2012-12-31S$37.09 M-30.95%
2011-12-31S$53.71 M155.71%
2010-12-31S$21 M